Tumor News and Research

RSS

Scientists develop new method to produce irradiated nanomaterials for medical applications

Under the leadership of Petr Cígler from the Institute of Organic Chemistry and Biochemistry and Martin Hrubý from the Institute of Macromolecular Chemistry, both of which are part of the Czech Academy of Sciences, a team of researchers has developed a revolutionary method for the easy and inexpensive production of irradiated nanodiamonds and other nanomaterials suitable for use in highly sensitive diagnostics of diseases, including various types of cancer.

12 Nov 2018

Scientists solve 125-year-old mystery of the brain, uncover potential treatment for epilepsy

Scientists at the Virginia Tech Carilion Research Institute have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for acquired epilepsy.

9 Nov 2018

Study uses gold nanoparticles to remove prostate cancer cells

A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is the first trial of its kind in the world.

9 Nov 2018

Salk researchers solve genetic 'whodunnit' for cancer gene

Long thought to suppress cancer by slowing cellular metabolism, the protein complex AMPK also seemed to help some tumors grow, confounding researchers. Now, Salk Institute researchers have solved the long-standing mystery around why AMPK can both hinder and help cancer.

8 Nov 2018

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Two recent studies find advances in radiation therapy are helping to prolong or improve the lives of people with anal cancer, including those whose cancer has advanced to stage IV.

8 Nov 2018

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Targeted tumor radiation provides a feasible treatment option for children with difficult-to-treat liver cancer, according to a new study published today in the journal Pediatric Blood and Cancer.

8 Nov 2018

Circadian clock could play key role in the fight against liver cancer

The body's internal clock could play a critical role in the fight against certain types of liver cancer, according to a preclinical study by scientists from The University of Texas Health Science Center at Houston (UTHealth). The results were published recently in the journal Nature Communications.

8 Nov 2018

Researchers discover gene signature biomarker that may predict patients' response to immune therapy

Scientists led by Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have discovered a gene signature biomarker that may predict which patients will respond - or not - to immune therapy.

8 Nov 2018

Researchers find new tiny molecule that is capable of killing medulloblastoma

A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer.

8 Nov 2018

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

8 Nov 2018

New study sheds light on how CAR T cell therapy works

Cancer remains the second-leading cause of death in the United States. This year, an estimated 1.7 million new cases will be diagnosed, with nearly 610,000 people expected to die from the disease, according to the National Cancer Institute.

8 Nov 2018

CDK2 protein plays key role in heart damage caused by doxorubicin, finds study

A new study by Washington State University researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.

8 Nov 2018

New open source decision support tool could help clinicians chose chemotherapy drugs

The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?

8 Nov 2018

New study shows promise of innovative strategy against HER2-driven lung cancers

The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year.

8 Nov 2018

Promising new glioblastoma treatment could improve and extend patients' lives

Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy.

7 Nov 2018

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Melbourne scientists have discovered how tumor development is driven by mutations in the most important gene in preventing cancer, p53.

7 Nov 2018

Scientists make strides in developing liquid biopsies for detecting brain tumor DNA

Scientists are making strides in developing liquid biopsies for brain tumors by detecting tumor DNA in the fluid from around the brain and spine.

7 Nov 2018

Treating pre-cancerous stem cells at early stage could be key to preventing bowel cancer

Treating pre-cancerous stem cells at an early stage could be key to preventing bowel cancer in people born with a very high risk of the disease, according to a study in mice presented at the 2018 NCRI Cancer Conference.

7 Nov 2018

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

The U.S. Department of Defense has granted the "Impact Award" to explore new therapeutic options against advanced prostate cancer - scientifically known as castration-resistant or hormone therapy resistant prostate cancer- to a multidisciplinary team of researchers made up of the Prostate Cancer Clinical Research Unit of the Spanish National Cancer Research Center, led by David Olmos, the Prostate Cancer Translational Research Group of the Vall d'Hebron Institute of Oncology, led by Joaquín Mateo, and the Genetics and Solid Tumors Laboratory of the University of Washington, led by Colin Pritchard.

7 Nov 2018

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

Researchers have developed a new nuclear medicine tracer that could improve diagnosis and treatment of non-small cell lung cancer.

7 Nov 2018

Tumor News and Research

Scientists develop new method to produce irradiated nanomaterials for medical applications

Scientists solve 125-year-old mystery of the brain, uncover potential treatment for epilepsy

Study uses gold nanoparticles to remove prostate cancer cells

Salk researchers solve genetic 'whodunnit' for cancer gene

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Circadian clock could play key role in the fight against liver cancer

Researchers discover gene signature biomarker that may predict patients' response to immune therapy

Researchers find new tiny molecule that is capable of killing medulloblastoma

Study could provide novel treatment strategy for potentially blinding problem

New study sheds light on how CAR T cell therapy works

CDK2 protein plays key role in heart damage caused by doxorubicin, finds study

New open source decision support tool could help clinicians chose chemotherapy drugs

New study shows promise of innovative strategy against HER2-driven lung cancers

Promising new glioblastoma treatment could improve and extend patients' lives

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Scientists make strides in developing liquid biopsies for detecting brain tumor DNA

Treating pre-cancerous stem cells at early stage could be key to preventing bowel cancer

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News